Offering self-sampling HPV tests for cervical cancer screening
Increasing Cancer Screening Among Female Patients at PSH St. Joseph's Residency Clinic: Offering a Self-sampling Option in Clinic
This study is testing if giving women the option to do their own HPV tests at home can encourage more of them to get screened for cervical cancer compared to the usual in-person tests.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 30 Years to 65 Years |
| Sex | Female |
| Sponsor | Milton S. Hershey Medical Center Academic / other |
| Locations | 1 site (Reading, Pennsylvania) |
| Trial ID | NCT05092022 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of self-sampled HPV tests in increasing participation in cervical cancer screening compared to traditional clinician-sampled tests. Patients at the PSH St. Joseph's residency clinic will be given the option to choose between a self-sampling HPV test or scheduling an in-person screening. The study will measure patient acceptability and completion rates of the self-sampling option, as well as overall increases in cervical cancer screenings within the patient population. The intervention involves providing patients with a self-sampling kit and instructions for use.
Who should consider this trial
Good fit: Ideal candidates are individuals who are due for cervical cancer screening and are not at greater than average risk for cervical cancer.
Not a fit: Patients who are pregnant, incarcerated, or at greater than average risk for cervical cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly increase cervical cancer screening rates among patients who may otherwise avoid traditional methods.
How similar studies have performed: Other studies have shown promising results with self-sampling approaches for cervical cancer screening, indicating potential for success in this study.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Eligible but out-of-date for cervical cancer screening * Able to speak, read, and communicate well in English or Spanish * Not at greater than average risk for cervical cancer Exclusion Criteria: * Pregnant * Incarcerated * Greater than average risk for cervical cancer, for example: * Already diagnosed with high-grade precancerous cervical cancer or cervical lesions * Has a compromised immune system * Unable to speak, read, and communicate well in English or Spanish * Unable or unwilling to give implied consent or otherwise complete study requirements
Where this trial is running
Reading, Pennsylvania
- Penn State Health St. Joseph's — Reading, Pennsylvania, United States (Recruiting)
Study contacts
- Principal investigator: Christina Scartozzi, DO — Penn State College of Medicine
- Study coordinator: Christina Scartozzi, DO
- Email: cscartozzi@pennstatehealth.psu.edu
- Phone: 610-208-4610
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.